Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-06-04-Speech-3-123"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20030604.3.3-123"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
".
As everyone knows, the overall aim of the Cartagena Protocol on Biological Safety
adopted on 29 January 2000, consists of contributing to ensuring an adequate level of protection in the field of the safe transfer, handling and use of genetically modified organisms (GMOs) produced by modern biotechnology, that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health, including cross-border movements in particular.
In line with the position of the Portuguese Government, however, I believe it is important that we now undertake this exercise at European level, in order to ensure the most important factor in this matter, which is a high degree of consumer protection. I therefore welcomed the adoption of the Council’s common position – and the approximation of positions that avoided the need for us to continue with a conciliation procedure – and, as such, the forthcoming entry into force of a regulation that is clear, technically secure and able to put the EU in a different position to the one that culminated, as a result of the diffuse nature of regulations, in the anti-GMO moratorium that led the USA to lodge a complaint with the World Trade Organisation."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples